Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2019 March
  • Home
  • Archive for March, 2019

Disruption in the Technology Age

  • March 12 2019

By Ross Youngs, March 12, 2019.  Disruption in the Technology Age Seems to Happen in Unexpected Places How new drug discovery will be impacted by a surrogate microbiome New York City, New York (March 12, 2019) – The pharmaceutical, agrochemical, and cosmetic industries all have similar pathways to discovering new products. Historically, all three sectors have

Continue Reading

RSS Industry News

  • Intestinal interoceptive dysfunction drives age-associated cognitive decline March 11 2026
  • Memory loss is fuelled by gut microbes in ageing mice March 11 2026
  • Magnetoreception in a freshwater ciliate arises from endosymbiosis March 10 2026
  • Forget SkinTok: the real science of skincare and why it matters for your health March 10 2026
  • Microbiome signatures of mangroves and salt marsh halophyte rhizosphere soil sediments: a metagenomic approach March 8 2026
  • HIV-associated gut microbiome influences gut mucosal immunity March 6 2026
  • Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial March 4 2026
  • Microbiota-mediated induction of beige adipocytes in response to dietary cues March 4 2026
  • Microplastics and nanoplastics in the human gut: from signals to standards March 4 2026
  • Early-life immunological and microbial differences between East African and North European children March 3 2026
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • Drug developer Generate Biomedicines raises $400 million in US IPO
  • Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
  • AI, Microbiomes, & 8 Orders of Magnitude Improvement
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2026. All Rights Reserved.